H-Index
14
Scimago Lab
powered by Scopus
eISSN: 1941-5923
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Logo


Get your full text copy in PDF

Leishmania in a Patient with Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia

Gregory Nicolas, Elliott Koury, Dani Osman, Christian Saliba, Lea Nehme, Stephanie Mitri, Julien-Sami Atef El Sayegh, Linda Rached, George Khoury

(Department of General Surgery, Lebanese American University Medical Center-Rizk Hospital (LAUMCRH), Beirut, Lebanon)

Am J Case Rep 2018; 19:512-516

DOI: 10.12659/AJCR.907584


BACKGROUND: Leishmaniasis is a parasitic infection spread by the bite of infected sand flies that are usually present in the Middle East, Africa, and some parts of Asia and Europe. Leishmaniasis manifests in 3 different forms: Visceral (also known as Kala Azar), which is the most serious type; cutaneous, which is the most common type; and mucocutaneous. The symptoms of this infection range from a silent infection to fever, enlargement of the liver and spleen, weight loss, and pancytopenia.
CASE REPORT: In this case report, we discuss a 73-year-old man known to have chronic lymphocytic leukemia (CLL), presenting with unremitting fever and who to our surprise was found to have Kala Azar.
CONCLUSIONS: Early diagnosis and treatment are very important in treating visceral leishmaniasis. While the conventional treatment in immunocompromised patients is liposomal amphotericin B, our patient responded to corticosteroids.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree